Home Archive
Archive
2025 Volume 56 Issue 9  Published: 2025-05-12
  • doi: 10.7501/j.issn.0253-2670.2025.09.001
    Objective To study the chemical constituents from Fupenzi (Rubi Fructus) and their antioxidant activities. Methods Chemical constituents were isolated and purified by chromatographic methods such as microporous adsorption resin, positive silica gel, ODS, Sephadex LH-20 and semi-preparative HPLC. The structures were identified by modern spectrum technology such as ESI-MS, NMR. The antioxidant activity of monomer compounds was evaluated in vitro by the scavenging ability of DPPH radicals. Results A total of 16 compounds were isolated from the 20% n-butanol extract of Rubi Fructus and identified as (erythro,erythro)-1-[4-[2-hydroxy-2-(4-hydroxy)-1-(hydroxymethyl)ethoxy]-3-methoxyphenyl]-1,2,3-propanetriol (1), (+)-catechin-5-O-β-D-glucoside (2), brevifolin carboxylic acid (3), (1'R,3'S,5'R,8'S,2Z,4E)-dihydrophaseic acid 3'-O-β-D- glucopyranoside (4), (−)-catechin (5), 3,4,5-trimethoxyphenyl-β-D-glucopyranoside (6), 2,4,6-trihydroxy-acetophenone-6-O-β-D-glucopyranoside (7), 3,4'-dihy-droxypropio- phenone-3-β-D-glucoside (8), trans-vaginoside (9), cis-vaginoside (10), dichotomoside E (11), dihydroconiferyl alcohol (12), 2-phenylethyl-β-D-glucopyranoside (13), dihydro-p-coumaryl alcohol γ-O-glucopyranoside (14), 2-hydroxynaringin-5-O-β-D-glucopyranoside (15), aromadendrin-7-O-β-glucopyranoside (16). The antioxidant activities of compounds 3, 5 and 16 were assessed through DPPH radical scavenging assay, with IC50 values determined to be 5.83, 1.13 and 8.46 μmol/L, respectively. Conclusion Among them, compound 1 is new lignan compound, named fupenzicmin, compounds 2, 4—16 are isolated from this plant for the first time. In vitro studies revealed that compounds 3, 5 and 16 display significant DPPH free radical scavenging capabilities and exhibit remarkable antioxidant activity.
  • doi: 10.7501/j.issn.0253-2670.2025.09.002
    Objective To study the chemical constituents of Polygonum lapathifolium. Methods The compounds were separated and purified by silica gel, Sephadex LH-20 column chromatography and semi-preparative HPLC. The structures were identified by NMR, MS, IR data analyses and literature data comparison. Their antioxidant activity was evaluated by using the DPPH method, the ABTS method and the hydroxyl radical scavenging method. Results A total of 20 compounds were isolated from the ethyl acetate of P. lapathifolium and elucidated as 2-methyl-5-n-undecylresorcinol (1), 5-n-dodecylresorcinol (2), (3S,5R)-dihydroxy-6R,7-megstigmadien-9-one (3), trans-phytol (4), kaempferol (5), quercetin (6), 2',4'-dihydroxy-6'-methoxychalcone (7), 2',6'-dihydroxy-4'-methoxychalcone (8), dihydroquercetin (9), 5,7,3',4'-tetrahydroxy-3-methoxyflavone (10), β-sitosterol (11), stigmaster-4-en-6β-hydroxy-3-one (12), ellagic acid-3,3'-dimethyl ether (13), ethyl gallate (14), methyl 2,4,6-trihydroxybenzoate (15), ethyl palmitate (16), 9(Z),12(Z)-octadecanedioenoic acid (17), methyl stearate (18), palmitic acid (19), oleic acid (20). Compounds 1―6, 9―14, 18 had the stronger DPPH, ABTS or OH radicals scavenging abilities and compound 1 showed significant abilities with IC50value of 0.023 mg/mL. Conclusion Compound 1 is a new resorcinol derivative, and named polygonumol A. Compounds 1―3, 13 and 15 are isolated from this genus for the first time. Compounds 1―6, 9―14, 18 exhibit significant antioxidant capacity.
  • doi: 10.7501/j.issn.0253-2670.2025.09.003
    Objective To rapidly identify the chemical components of Buzhong Yiqi Decoction and the distribution characteristics of the main absorbed and tissue-migrating constituents in mice after intragastric administration by UHPLC-Q-Exactive Orbitrap HRMS. Methods A total of 12 male C57/BL6J mice were taken, divided into blank group (n = 3) and treatment group (n = 9), the blank group was gavaged with pure water, the treatment group was gavaged with Buzhong Yiqi Decoction extract at 21 g/kg. Three mice were sacrificed at 0.5, 1 and 3 h after the administration of the drug, respectively, and serum and tissue samples were collected, and the pretreatment process was performed by protein precipitation. Using an ACQUITY UPLC BEH C18 column (100 mm×2.1 mm, 1.7 µm), the mobile phase was 0.1% formic acid aqueous solution (A)-methanol (B) with gradient elution. Mass spectrometry collected data using a first-stage full scan of positive and negative ions/data-dependent second-stage scan mode, and based on the relative retention time of ion peaks and the information of primary fragment ions, the constituent elements were fitted with Xcalibur 4.2 software. Through the comparison of reference substances, literature and secondary fragment ion information provided by the database, the identification of the chemical components of Buzhong Yiqi Decoction and the components that enter the blood and migrate to various tissues was achieved. Results A total of 286 chemical constituents were identified from Buzhong Yiqi Decoction, 117 kinds of flavonoids, 109 kinds of terpenes, 29 kinds of organic acids, 13 kinds of phthalein, 5 kinds of coumarins and 13 other kinds of compounds (two kinds of phenylethanol glycosides, one kind of phenylpropanol glycoside, two kinds of chromones, one kind of chromone, one kind of alkaloid and one kind of lignan). On the basis of identified compounds in the extract, 101, 100, and 102 kinds of compounds were detected in the 0.5, 1, and 3 h of mice serum smples after intragastric administration of Buzhong Yiqi Decoction. A total of 146, 88, 149, 138, 118, 205, 107 and 116 kinds of prototype compounds were identified in lung, heart, liver, spleen, kidneys, ileum, anterior tibialis and gastrocnemius, respectively. Conclusion In this study, the chemical components of Buzhong Yiqi Decoction and the absorbed components into serum and tissue-migrating components were rapidly identified by HRMS, which could provide a reference for the analysis of the effective substances of Buzhong Yiqi Decoction and the in-depth study of the pharmacokinetics of the effective components in different tissues.
  • doi: 10.7501/j.issn.0253-2670.2025.09.004
    Objective To explore the active fractions and chemical components with spleen-invigorating effect from raw rhizomes of Atractylodes macrocephala. Methods The rat model of spleen-deficiency was replicated by the method of “ig senna leaves + fatigued swimming + abnormal hunger and satiety”, Which was treated with water extract from raw rhizomes of A. macrocephala, polysaccharides and non-polysaccharide parts. The effective fractions of raw rhizomes of A. macrocephala in treating spleen deficiency were evaluated using various indicators, including general behavioral characteristics, gastrointestinal (GI) transit rate, gastric residual rate, digestive and absorption functions, water and fluid metabolism, tissue pathological structure, and neurotransmitters of rats with spleen-deficiency. The non-polysaccharide part was subjected to chromatography on a HP-20 macroporous resin column eluted with different concentrations of aqueous ethanol. The intestine epithelial cell (IEC-6) growth inhibition model induced by α-difluoromethylornithine (DFMO) was applied to assay the cell viability of the obtained fractions. The chemical constituents in the active fraction were analyzed by ultra-performance liquid chromatography coupled with quadrupole time-of-flight mass spectrometry (UPLC-Q-TOF/MS). The main constituents were isolated and evaluated for their impact on IEC-6 cell viability induced by DFMO. Results The water extract and non-polysaccharide part from raw rhizomes of A. macrocephala significantly improved the symptoms of spleen-deficiency rats, mainly by regulating neurotransmitter levels, promoting gastrointestinal motility, repairing tissue damage, enhancing digestive and absorption capabilities, and modulating inflammatory factors. The 90% ethanol-elution fraction from non-polysaccharide part (CT-90E) at concentrations of 0.1—0.15 mg/L could reverse the growth inhibition of IEC-6 cells induced by DFMO. The main components in CT-90E, including 8-epiatylenolide (12.5—100 μmol/L), atractylenolide II (50—100 μmol/L), atractylenolide I (25—50 μmol/L), and phthalic acid (12.5—50 μmol/L) could reverse the growth inhibition of IEC-6 cells induced by DFMO. Conclusion The water extract of raw rhizomes of A. macrocephala exhibits significant effect in treating spleen deficiency, with the non-polysaccharide part identified as the active part responsible for treating spleen deficiency. Among the fractions of non-polysaccharide part, CT-90E promotes the repair of intestinal mucosa, with 8-epiatylenolide, atractylenolide II, atractylenolide I, and phthalic acid identified as the main active components responsible for mucosal repair.
  • doi: 10.7501/j.issn.0253-2670.2025.09.005
    Objective Taking Chuanbei Pipa Syrup (CPS, 川贝枇杷糖浆) as the research object, this study aims to establish the identification and evaluation methods for its taste critical quality attribute (CQA). Based on these methods, research on its taste improvement strategy is conducted to improve patients’ medication compliance. Methods Firstly, the taste assignment method was used to identify the taste CQA in CPS. Secondly, the taste CQA evaluation method of CPS was established based on human senses and electronic tongue. Finally, the taste improvement strategy for CPS intermediate was established based on human-machine interaction. Results The bitterness of CPS accounted for 53.42% of the total taste, and it was determined that bitterness is the taste CQA that led to the poor taste of CPS. Based on the safety, solubility, sweetness, and other limiting conditions, the optimal taste formula for per milliliter of CPS intermediate was made up of 4.8 mg stevia, 90 mg erythritol and 90 mg trehalose. Compared with the CPS product, the sensory evaluation score of the sample after flavoring was improved by 14 points. Conclusion This study focuses on CPS and develops a set of taste improvement strategies from identification of taste CQA to formula optimization. It provides ideas and methods for effectively addressing the adverse taste of Chinese patent drug.
  • doi: 10.7501/j.issn.0253-2670.2025.09.006
    Objective To explore the optimal processing technology for Fuling (Poria) decoction pieces. Methods Through market and literature research, it was found that the commonly used processed products of Poria cocos mainly include the following six processing methods: fresh cutting, sun drying, shade drying, sweating, steaming, and sweating steaming. Orthogonal experiments combined with comprehensive scoring were used to optimize six sets of process parameters. HPLC and phenol sulfuric acid methods were used to measure the contents of poricoic acid A, poricoic acid B, dehydropachymic acid, 3-dehydrotrametenolic acid and Poria polysaccharide in the six groups of Poria processed products. An Agilent Eclipse XDB-C18 chromatographic column (250 mm×4.6 mm, 5 μm) was used, with 0.1% formic acid aqueous solution-acetonitrile as the mobile phase, gradient elution was performed. The column temperature was 35 ℃, the injection volume was 5 μL, and the volumetric flow rate was 1 mL/min. Quantitative study was conducted on the content of triterpenoid acids and Poria polysaccharides in six different processing techniques of Poria. Results The content of triterpenoids and polysaccharides of Poria was highest in the shade drying group (humidity 90%, temperature 23 ℃, 4mm slice), with a comprehensive score of 0.896, which was the highest compared to the other processing groups. The analysis of variance showed that relative humidity (P < 0.01) and fermentation temperature (P < 0.05) were key factors in the shade drying process. Conclusion Based on quantitative analysis of multi-index components, this study provides a material research basis and scientific basis for precise quality control and clinical application of the processing technology of of Poria decoction pieces.
  • doi: 10.7501/j.issn.0253-2670.2025.09.007
    Objective To establish the HPLC fingerprint profiles of Baizhi (Angelicae Dahuricae Radix, ADR) medicinal materials, decoction pieces, standard decoctions, fluid extracts, and serum samples, and screen quality markers (Q-Marker) of ADR based on its quality transfer process. Methods A total of ten batches of ADR medicinal materials were collected and processed into decoction pieces, standard decoctions, fluid extracts, and serum samples. The fingerprint profiles of the five types of samples were established by using HPLC technology. The Q-Marker of ADR were screened through similarity evaluation and analysis of the content and transfer rates of indicator components. Results A total of eight high-similarity characteristic peaks were identified in the fingerprint profiles of ADR samples (medicinal materials, decoction pieces, standard decoctions, fluid extracts, and serum). During the transfer from medicinal materials to decoction pieces, the average transfer rates of seven key components (imperatorin, bergapten, byakangelicin, isoimperatorin, osthole, oxypeucedanin hydrate, and arginine) exceeded 61%, indicating stable transfer. In the transfer from decoction pieces to standard decoctions, the coumarin components oxypeucedanin hydrate, byakangelicin, and bergapten were stably transferred (> 60%). However, the transfer rate of arginine was abnormally high (> 700%), while the content of imperatorin and isoimperatorin was low with transfer rates < 20%, and osthole was not detected. During the transfer from standard decoctions to fluid extracts, arginine, oxypeucedanin hydrate, and byakangelicin were stably transferred (> 70%). In the transfer from fluid extracts to serum samples, only arginine, oxypeucedanin hydrate, and byakangelicin were detected and transferred, while the other components were not detected. Conclusion Based on the fingerprint profiles, content, and transfer rate changes of ADR medicinal materials, decoction pieces, standard decoctions, fluid extracts, and serum samples, oxypeucedanin hydrate and byakangelicin were screened as Q-Marker of ADR.
  • doi: 10.7501/j.issn.0253-2670.2025.09.008
    Objective To disintegrate the phases of Huangqin Decoction (HD, 黄芩汤) and investigate the anti-dermatophyte effects of different phases. Methods HD was split into precipitation phase (HD-P), solution phase (HD-S) and nano phase (HD-N) by high-speed centrifugation combined with membrane dialysis, and each phase was characterized. The contents of HD active components, polysaccharides and proteins in different phases were determined by HPLC, phenol sulfuric acid method and bicinchoninic acid assay (BCA). The release characteristics of the main components in different phase states were investigated by Franz diffusion cell. Microdilution method was used to investigate the antifungal effects of different phases of HD on four common clinical dermatophytes, and Trichophyton mentagrophytes was used as the model strain. The effects of different phases of HD on mycelial growth, spore germination and biomass synthesis were studied. Results A total of 10 components (albiflorin, paeoniflorin, liquiritin apioside, baicalin, melaleuca glycoside A, wogonoside, baicalein, glycyrrhizic acid, wogonin and oroxylin A), protein and polysaccharide were mainly distributed in HD-N. The cumulative dissolution rate of albiflorin and paeoniflorin was HD-S > HD-N > HD > HD-P. The cumulative dissolution rate of liquiritin apioside, baicalin, wogonoside and glycyrrhizic acid was HD-N > HD > HD-S > HD-P; The minimum inhibitory concentration (MIC) of each phase was: HD-N (0.78—1.56 mg/mL) < HD (1.56—6.25 mg/mL) < HD-S (12.50—25.00 mg/mL) < HD-P (> 100.00 mg/mL); The inhibitory effects of different phases of HD on mycelium growth, spore germination and biomass synthesis were as follows: HD-N was the best (P < 0.05, 0.01), followed by HD, HD-S and HD-P. Conclusion The antifungal activity of different phases of HD is closely and positively related to the distribution of main components and in vitro cumulative dissolution, that is, the higher the content of main components and the higher the cumulative dissolution rate of components, the stronger the antifungal effect of phase.
  • doi: 10.7501/j.issn.0253-2670.2025.09.009
    Objective By analyzing the difference of components of Chaihu (Bupleuri Radix, BR) by vinegar wetting and honey bran fried during processing, the effects of Jianchangbang’s characteristic processing methods on the changes of components of BR were explored, and the differential components were screened to lay a foundation for revealing its processing mechanism. Methods The UPLC-LTQ-Orbitrap MS technology was used to analyze the chemical components of BR, stir-fried BR (sfBR) and during the processing. The SIMCA 14.1 software was used to conduct principal component analysis (PCA) and orthogonal partial least squares-discriminant analysis (OPLS-DA) on the sample data. The variable importance in projection (VIP) value > 1 was used as an indicator to screen out differential components. Results A total of 63 chemical components were identified from BR, and 66 chemical components were identified from sfBR, including saikosaponins, flavonoids, organic acids, coumarins and others. A total of 21 differential components were screened out before and after processing [baicalin, L-(−)-arabitol, gluconic acid, apigenin, citric acid, L-(−)-malic acid, (15Z)-9,12,13-trihydroxy-15-octadecenoic acid, saikosaponin a, azelaic acid, saikosaponin b2, 12,13-dihydroxy-9-octadecenoic acid, D-(−)-quinic acid, trans-6-hydroxyoctadec-4-enoic acid, (±)-9-hydroperoxyoctadeca-10,12-dicarboxylic acid, matairesinol, 2″-O-acetylsaikosaponin a, chlorogenic acid, 9,10,13-trihydroxy-11-octadecenoic acid, saikogenin f, saikosaponin d, and wogonin]. By comparing the peak area, it was found that the relative contents of apigenin, L-(−)-malic acid, (15Z)-9,12,13-trihydroxy-15-octadecenoic acid, azelaic acid, saikosaponin b2, 12,13-dihydroxy-9-octadecenoic acid, trans-6-hydroxyoctadec-4-enoic acid, (±)-9-hydroperoxyoctadeca-10,12-dicarboxylic acid, chlorogenic acid, 9,10,13-trihydroxy-11-octadecenoic acid, saikogenin f, and wogonin increased, the relative contents of baicalin, L-(−)-arabitol, saikosaponin a, matairesinol, 2″-O-acetylsaikosaponin a, and saikosaponin d decreased, and gluconic acid, citric acid and D-(−)-quinic acid were newly added components after processing. During the processing of BR, it was found through analysis that there were significant differences among raw products, after being moistened with vinegar, and after being fried with honey bran. A total of 23 differential components were screened out [citric acid, gluconic acid, (15Z)-9,12,13-trihydroxy-15-octadecenoic acid, baicalin, 9,10,13-trihydroxy-11-octadecenoic acid, matairesinol, saikosaponin a, apigenin, (±)-9-hydroperoxyoctadeca-10,12-dicarboxylic acid, isorhamnetin, saikogenin f, 12,13-dihydroxy-9-octadecenoic acid, maleic acid, chlorogenic acid, ephedra fatty acid f, 2,4-dihydroxy-2,3-bis[(4-hydroxy-3-methoxyphenyl) methyl]butanoic acid, saikosaponin d, 3-hydroxy-3,5,5-trimethyl-4-(3-oxo-1-buten-1-ylidene) cyclohexyl-I(2)-D-glucothioside, guanosine, saikosaponin e, 15,16-dihydroxy-10,13-octadecadienoic acid, D-(+)-arabitol, and 1-O-[(3β,5ξ,9ξ)-3-(β-D-glucosyl)-27-hydroxy-27,28-dioxoolean-12-en-28-yl]-β-D-glucopyranose]. Conclusion After BR is processed with vinegar moistening to stir-baking with honey bran, the saponin components are converted, the types and contents of phenolic acid components increase, the content of irritating components decreases, and the component differences at different processing stages are relatively significant. This study can lay a foundation for in-depth study of the processing mechanism of BR by vinegar moistening to stir-baking with honey bran.
  • doi: 10.7501/j.issn.0253-2670.2025.09.010
    Objective To optimize the best processing technology for salt-processed Shayuanzi (Astragali Complanati Semen, ACS) and investigate its anti-inflammatory effects before and after processing. Methods Based on single-factor experiments, a L9(34) orthogonal experimental design combined with the technique for order preference by similarity to ideal solution (TOPSIS) method was employed. The content changes of seven flavonoid components (leucoside, astragalin, complanatoside B, complanatoside, myricetin, kaempferol, and kaempferide) were used as evaluation indicators, the optimal salt-stir-frying process was obtained and verified. Additionally, a 2,4,6-trinitrobenzenesulfonic acid (TNBS)-induced zebrafish enteritis model was established to compare the anti-inflammatory effects of ACS before and after salt processing. Results The optimal salt-stir-frying process for ACS was determined as follows: for every 30 g of ACS, 4 mL of 2% salt water was added, followed by an 8-hour soak and stir-frying at 100 ℃ for 15 min. The pharmacodynamic experimental results showed that the salt-processed ACS was slightly better than the ACS in improving intestinal tissue disorders in the zebrafish enteritis model and reducing the release of tumor necrosis factor-α (TNF-α), interleukin-1β (IL-1β), IL-6 and IL-8. Conclusion The processing technology of salt-processed ACS optimized by the entropy weight TOPSIS method is stable and feasible. The aqueous extract of salt-processed ACS exhibits stronger anti-inflammatory effects than the raw material, providing a reference for elucidating the processing-enhanced mechanism of salt-processed ACS.
  • doi: 10.7501/j.issn.0253-2670.2025.09.011
    Objective To study the effect of total flavonoids from Shayuanzi (Astragali Complanati Semen, TFACS) on hepatic fibrosis (HF) mice based on iron metabolism in hepatic stellate cells (HSCs). Methods HF mice model was established by ip 10% carbon tetrachloride (CCl4) for eight consecutive weeks. HF mice were randomly divided into control group, model group, silibinin (100 mg/kg) group, and TFACS low-, high-dose (8, 20 mg/kg) groups. The mice were administered continuously for six weeks, and serum was collected 16 h after the last administration. Liver and spleen indexes were calculated; Serum liver function index was measured by automatic serum biochemical instrument; ELISA was used to measure the levels of collagen type IV (Col-IV), hyaluronic acid (HA), laminin (LN) and procollagen Ⅲ (PCⅢ) in serum; The liver lesions and collagen deposition were observed by hematoxylin-eosin (HE) and Masson staining; The contents of hepcidin, iron and MDA in liver tissue were determined by kit; The distribution of iron in liver tissue was observed by prussian blue staining; Western blotting was used to detect the expressions of Collagen Ⅰ, Collagen Ⅳ, α-smooth muscle actin (α-SMA) and transferrin receptor (TFRC) in liver tissue. Transforming growth factor-β1 (TGF-β1) was used to induce the activation of HSC-T6 cells, and the effect of TFACS on the proliferation of cells was evaluated by CCK-8 method, the contents of MDA and iron in cells were determined by kits, the level of reactive oxygen species (ROS) in cells was detected by immunofluorescence method, the expressions of α-SMA and TFRC proteins in cells were detected by Western blotting. Results TFACS significantly reduced the spleen index of HF mice (P < 0.05, 0.01), reduced the activities of alanine aminotransferase (ALT), aspartate aminotransferase (AST), alkaline phosphatase (ALP) and levels of Col-IV, HA, LN and PCIII in serum (P < 0.05, 0.01, 0.001), improved liver cell injury, inflammatory infiltration and collagen deposition in HF mice, reduced the iron staining area of liver tissue (P < 0.05), decreased the levels of hepcidin, iron and MDA in liver tissue (P < 0.05, 0.01), and down-regulate the expressions of Collagen I, Collagen IV, TFRC and α-SMA proteins in liver tissue (P < 0.05). In addition, TFACS could significantly inhibit the proliferation of HSC-T6 cells induced by TGF-β1 (P < 0.05, 0.01), down-regulate the expressions of TFRC and α-SMA proteins (P < 0.05, 0.01), and reduce MDA, ROS and iron levels (P < 0.001). Conclusion TFACS has a protective effect on HF, and its mechanism may be related to regulating iron metabolism in HSCs.
  • doi: 10.7501/j.issn.0253-2670.2025.09.012
    Objective To explore the antiviral effect of Yuxingcao (Houttuyniae Herba) in vitro and in vivo, as well as its activation effect on natural immune signals against viruses. Methods CCK-8 method was used to detect the effect of Houttuyniae Herba water extract on viability of A549 cells; A549 cells was infected with vesicular stomatitis virus expressing green fluorescent protein (VSV-eGFP), the effect of Houttuyniae Herba water extract on virus replication was detected by flow cytometry; qRT-PCR was used to detect the effect of Houttuyniae Herba water extract on the replication of influenza A virus (H1N1), encephalomyocarditis virus (EMCV) and herpes simplex virus type 1 (HSV-1); Antiviral mechanism of Houttuyniae Herba was explored by bioinformatics methods and validated through qRT-PCR; The antiviral effect of Houttuyniae Herba water extract was detected in wild-type and type I interferon receptor 1 (IFNAR1) knockout A549 cells, and the effects of Houttuyniae Herba water extract on downstream TANK binding kinase 1 (TBK1), signal transducer and activator of transcription 1 (STAT1) and STAT2 phosphorylation levels in interferon-I (IFN-I) pathway were examined by Western blotting. A mouse model infected with H1N1 virus was constructed and oseltamivir was used as a positive control drug to investigate the effect of Houttuyniae Herba water extract on viral load and pathological changes in lung tissue of infected mice. Results At the cellular level, Houttuyniae Herba water extract significantly inhibited the replication of VSV, H1N1, EMCV and HSV-1 (P < 0.05, 0.01, 0.001), and showed a dose-dependent effect. In the H1N1 infected mouse model, Houttuyniae Herba water extract significantly reduced the viral load in lung tissue (P < 0.05), and improved the pathological damage of lung tissue. Mechanism studies showed that Houttuyniae Herba water extract significantly up-regulated the expressions of interferon stimulated genes (ISGs) in MEF, THP-1 and PM cells (P < 0.05, 0.01, 0.001), and promoted the phosphorylation of TBK1, STAT1 and STAT2 (P < 0.05, 0.01, 0.001). Conclusion Houttuyniae Herba water extract exerts antiviral effects both in vitro and in vivo by activating IFN-I pathway based antiviral innate immunity.
  • doi: 10.7501/j.issn.0253-2670.2025.09.013
    Objective To investigate the protective effect and related mechanism of ginkgo diterpene lactone (GDL) on platelet-activating factor (PAF)-induced neuronal injury. Methods A cellular model and an animal model of PAF-induced neuronal injury were constructed, GDL or PERK agonist CCT020312 were administered. The cell viability and apoptosis of HT22 cells were determined using CCK-8 and Annexin V-FITC apoptosis assay kits, respectively; Activity of lactate dehydrogenase (LDH) in HT22 cell culture supernatant was measured using a LDH assay kit, and calcium level in HT22 cells was determined using a Fluo-4 calcium assay kit; Molecular docking was used to explore the relevant molecular mechanisms; Western blotting was used to detect the expressions of apoptosis-related proteins [cystein-asparate protease-3 (Caspase-3), cleaved Caspase-3, B-cell lymphoma-2 (Bcl-2), Bcl-2 associated X protein (Bax)] and endoplasmic reticulum stress-related proteins [protein kinase R-like ER kinase (PERK), p-PERK, eukaryotic initiation factor-2α (eIF-2α), p-eIF2α, activating transcription factor 4 (ATF4), C/EBP-homologous protein (CHOP)] in HT22 cells and brain tissues of mice. Results The results of in vitro cell experiments showed that, compared with control group, cell activity was significantly reduced in model group (P < 0.001), release rate of LDH was increased (P < 0.001), level of calcium ions was increased (P < 0.001), number of apoptotic cells was significantly increased (P < 0.001), the expression levels of cleaved Caspase-3 and Bax proteins were significantly increased (P < 0.001), the expression level of Bcl-2 protein was significantly decreased (P < 0.001), and the expression levels of endoplasmic reticulum stress-related proteins were significantly increased (P < 0.05, 0.001). Compared with model group, GDL significantly increased cell viability (P < 0.05, 0.001), significantly up-regulated Bcl-2 expression (P < 0.05, 0.001), and significantly down-regulated the expression of cleaved Caspase-3, Bax, p-PERK, p-eIF2 α, ATF4 and CHOP (P < 0.05, 0.01, 0.001); The effect of GDL after CCT020312 treatment was reversed (P < 0.001). The results of in vivo animal experiments showed that compared with control group, the expression level of Bax protein in brain tissue of mice in model group was significantly increased (P < 0.001), the expression level of Bcl-2 protein was significantly decreased (P < 0.001), and the expression levels of endoplasmic reticulum stress-related proteins were significantly increased (P < 0.001); Compared with model group, GDL significantly up-regulated the expression of Bcl-2 (P < 0.01, 0.001), and significantly down-regulated the expressions of p-PERK, p-eIF2α, ATF4, CHOP and Bax (P < 0.001); The effect of GDL after CCT020312 treatment was reversed (P < 0.001). Conclusion PAF can active PERK/ATF4/CHOP pathway of neuronal endoplasmic reticulum stress to induce calcium overload and thus neuronal apoptosis, whereas GDL can inhibit endoplasmic reticulum stress, calcium overload and apoptosis by inhibiting PERK/ATF4/CHOP pathway to attenuate PAF-induced neuronal injury.
  • doi: 10.7501/j.issn.0253-2670.2025.09.014
    Objective To explore the mechanism of Liushen Gel (六神凝胶) in treatment of acne based on network pharmacology and animal experiments. Methods The active ingredients and targets of Liushen Gel were screened by network pharmacology, and the protein interaction network between the active ingredient targets and acne disease targets was analyzed by String database. Gene ontology (GO) function and Kyoto encyclopedia of genes and genomes (KEGG) pathway enrichment analysis of targets of Liushen Gel for acne treatment were conducted by DAVID database. The rat model of acne was established by intradermal injection of Propionibacterium acnes and external application of oleic acid. The effects of Liushen Gel on the appearance, pathological changes, and levels of inflammatory factors in ear tissue of rats were investigated. Western blotting was used to detect the expressions of Toll-like receptor 2 (TLR2)/p38/nuclear factor-κB (NF-κB) pathway related proteins in ear tissue of rats, and immunofluorescence was used to detect the expression of NF-κB p65 in ear tissue of rats. Results A total of 27 active ingredients from Liushen Gel, 831 drug targets, 120 acne targets and 41 cross targets of active ingredients and diseases were obtained. The main ingredients of Liushen Gel in the treatment of acne were muscone, cholesterol, campesterol, cholalic acid and morphine, the core targets were tumor necrosis factor (TNF), interleukin-1β (IL-1β), leptin (LEP), TLR4 and CXC chemokine ligand 8 (CXCL8), the key signal pathways may included IL-17 signaling pathway, TLR signaling pathway, NOD like receptor signaling pathway, C-type lectin receptor signaling pathway, TNF signaling pathway and NF-κB signaling pathway, etc. The animal experiment results showed that Liushen Gel could significantly alleviate the symptoms of acne in ear of rats, reduce the degree of ear swelling, significantly inhibit the levels of TNF-α, IL-1β, IL-6, IL-8, IL-17, IL-23 and matrix metalloproteinase 9 (MMP9) in ear tissue (P < 0.001), significantly reduce the expression levels of TLR2, p38 and p-NF-κB p65 proteins in acne tissue (P < 0.01, 0.001). Conclusion Liushen Gel could treat acne by inhibiting the activation of TLR2/p38/NF-κB signaling pathway, reducing the secretion of inflammatory factors and alleviating the inflammatory response of acne model rats.
  • doi: 10.7501/j.issn.0253-2670.2025.09.015
    Objective To explore the pharmacological effects and mechanism of volatile oil from Atractylodes chinensis on insomnia based on gas chromatography-mass spectrometry (GC-MS) technology combined with animal experiments, and prepare volatile oil from A. chinensis microemulsion. Methods GC-MS was used to analyze the chemical composition of volatile oil from A. chinensis. Insomnia model was induced by chlorpheniramine (300 mg/kg), control group, model group, diazepam (1.3 mg/kg) group, and volatile oil from A. chinensis low-, medium-, high-dose (23.4, 46.8, 93.6 mg/kg) groups were set up, changes in body weight, sleep and spontaneous activity of mice before and after administration were evaluated; Hematoxylin-eosin (HE) staining was used to observe the morphology of brain tissue in mice; ELISA was used to measure the levels of 5-hydroxytryptamine (5-HT), glutamic acid (Glu), γ-aminobutyric acid (GABA), tumor necrosis factor-α (TNF-α), interleukin-1 (IL-1) and IL-6 in brain tissue; qRT-PCR was used to detect the mRNA expressions of cyclic adenosine monophosphate (cAMP), protein kinase A (PKA), cAMP-response element binding protein (CREB), brain-derived neurotrophic factor (BDNF) and tyrosine kinase receptor B (TrkB) in brain tissue; Western blotting was used to detect the protein expressions of cAMP, PKA, CREB, BDNF and TrkB in brain tissue. The volatile oil from A. chinensis microemulsion was prepared by titration method, single factor experiment was used to investigate the effects of different surfactants, co-surfactants, and the mass ratio of surfactants to co surfactants (Km) on the formation of microemulsion of A. chinensis volatile oil, the quality of microemulsion appearance, type, temperature stability, centrifugal stability and physical properties were evaluated; The distribution characteristics of microemulsion of A. chinensis volatile oil in mice was studied through live animal fluorescence imaging experiments. Results GC-MS identified 50 chemical components in volatile oil from A. chinensis, mainly including alcohols, aromatic hydrocarbons, olefins, esters and ketones. The volatile oil from A. chinensis could significantly increase the body weight of insomnia mice (P < 0.05), shorten the sleep latency of mice (P < 0.01), prolong the sleep time of mice (P < 0.05, 0.01), improve the infiltration of inflammatory cells in brain tissue, reduce the number of independent activities (P < 0.01), significantly increase the levels of 5-HT and GABA in brain tissue (P < 0.01), reduce the levels of Glu, IL-1, IL-6 and TNF-α in brain tissue (P < 0.05, 0.01), and up-regulate the expressions of cAMP, PKA, CREB, BDNF and TrkB in brain tissue (P < 0.05, 0.01). The optimal formulation process for microemulsion was to use polysorbate 80 as the surfactant, anhydrous ethanol as the co-surfactant, Km = 2; The quality evaluation found that microemulsion of A. chinensis volatile oil was yellow in color, uniform, transparent, and clear in appearance, with good fluidity. The diffusion rate of methylene blue in the microemulsion was significantly faster than that of Sudan red. After centrifugation at a speed of 1 000—4 000 r/min and standing at a temperature of 5—45 ℃, the appearance of the microemulsion remained unchanged, which proves its good centrifugal stability and temperature stability. The average particle size, polymer dispersion index (PDI), and pH value of the microemulsion were (159.00 ±4.53) nm, 0.451 ±0.012, and 6.74 ±0.02, respectively. The results of live animal imaging experiments showed that microemulsion of A. chinensis volatile oil could reach brain tissue through the blood-brain barrier and has good sustained release effect. Conclusion The volatile oil from A. chinensis has a sedative effect, providing a theoretical basis for the improvement of insomnia by microemulsion of A. chinensis volatile oil.
  • doi: 10.7501/j.issn.0253-2670.2025.09.016
    Objective To explore the inhibitory effect of hesperidin on stemness of hepatoma cells by targeting β-catenin, and evaluate its enhancing effect on sorafenib sensitivity. Methods HepG2 cells in logarithmic growth phase were selected, and control group, hesperidin low-, high-dose (0.5, 1.5 mmol/L) groups were set up for tumor spheroidization experiments, Western blotting and immunofluorescence techniques were used to detect the expressions of stemness related proteins, and qRT PCR was used to detect the expressions of stemness related genes. After one week of HepG2 cells culture, the half inhibitory concentration (IC50) curve of cells against sorafenib was measured to observe cell proliferation and apoptosis. A stable HepG2 cell line overexpressing β-catenin was constructed, overexpressing β-catenin group and overexpressing β-catenin + hesperidin (1.5 mmol/L) group were set up for tumor spheroidization experiments, and the expressions of stemness related proteins were detected; The IC50 curve of cells against sorafenib was measured to observe cell proliferation and apoptosis. After injecting HepG2 cells into nude mice, hesperidin or sorafenib was administered, tumor size was regularly observed and recorded. Immunohistochemistry and Western blotting were used to detect the expressions of Ki67, β-catenin, cysteine aspartate protease-3 (Caspase-3), CD44 and CD133 proteins in tumor tissue. Results Hesperidin could effectively inhibit the spheroidization ability of tumor cells (P < 0.001), reduce the volume and quantity of cell spheroids (P < 0.001), and significantly decrease the expressions of stemness related proteins (P < 0.001). In addition, hesperidin could enhance the sensitivity of tumor cells to sorafenib and affect the localization of β-catenin. The in vivo experimental results showed that hesperidin had anti-tumor effects, and the combination with sorafenib had a better effect. Conclusion Hesperidin inhibits the stemness of hepatoma cells by targeting β-catenin, and significantly enhances the sensitivity of sorafenib to hepatoma cells.
  • doi: 10.7501/j.issn.0253-2670.2025.09.017
    Objective To investigate the curative effect of Qingke Pingchuan Granule combined with conventional Western medicine in the treatment of bronchiectasis and its effect on the acute exacerbation of bronchiectasis patients after discharge. Methods A retrospective analysis was performed on 122 patients with bronchiectasis discharged from the pulmonary Department of Longhua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine from February 2021 to June 2023, and they were divided into treatment group (n = 61) and control group (n = 61) according to different treatment regiments. The control group only received conventional Western medicine treatment after discharge, the course of treatment was one week; and the treatment group combined with Qingke Pingchuan granules on the basis of the control group. The course of treatment of Qingke Pingchuan granules was eight weeks. The patients were followed up for 24 weeks after discharge. The proportion of acute exacerbations within 24 weeks after discharge, St. George's Respiratory Questionnaire (SGRQ) scores and pulmonary function indicators at baseline and 24 weeks after enrollment were compared between the two groups, and adverse events were recorded. Results The total effective rate of the treatment group was 65.6%, and that of the control group was 44.3%. The difference was statistically significant (P < 0.05). Within 24 weeks after discharge, the rate of acute exacerbations in the treatment group was lower than that in the control group (19.7% vs 36.1%, P < 0.05). Compared with the control group, the time of recurrence of acute exacerbations in the treatment group was longer [(157.18 ±44.07) d vs (137.23 ±57.14) d, P < 0.05]. At the 24 weeks after enrollment, SGRQ scores (symptoms, activities, psychological scores and total scores) in both groups were lower than those at baseline (P < 0.05). The improvement value of SGRQ activity score in the treatment group was higher than that in control group (P < 0.05). At the 24 weeks after enrollment, the pulmonary function indexes (FEV1, FVC, FEV1/FVC) of the two groups were higher than those at baseline, and the difference was no significant difference (P > 0.05). There was no significant difference in the improvement value of lung function between the treatment group and the control group (P > 0.05). There was no significant difference in the incidence of total adverse reactions between the two groups (P > 0.05). Conclusion Qingke Pingchuan Granule combined with conventional Western medicine regimen can effectively reduce the risk of re-acute exacerbation in patients with bronchiectasis within 24 weeks after discharge, help improve chronic respiratory symptoms and mobility, and has a good safety.
  • doi: 10.7501/j.issn.0253-2670.2025.09.018
    Objective This study aims to screen biomarkers for Alzheimer’s disease (AD), elucidate its pathogenesis, and explore potential therapeutic targets and blood-absorbed constituents (BACs) by integrating network inference algorithms, machine learning, drug-likeness evaluation, molecular docking, and molecular dynamics simulations. Methods Classical TCM formulas containing BACs were screened based on the database of constituents absorbed into the blood and metabolites of traditional Chinese medicine (DCABM-TCM) and the corresponding syndromes and their targets were retrieved from the from syndrome ontology to network-based evaluation of syndrome ontology and formula database (SoFDA). The weighted signed directed tensor network-based inference (wSDTNBI) algorithm was used to predict BACs targets. Differential expressed genes (DEGs) related to AD were identified by mining the GEO database. Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) analyses were performed to explore the biological processes and pathways associated with up- and down-regulated DEGs. Core AD genes were screened using the least absolute shrinkage and selection operator (LASSO), support vector machine-recursive feature elimination (SVM-RFE), protein-protein interaction (PPI) network analysis, and text mining. Candidate BACs were further filtered using pan-assay interference compounds (PAINS), Lipinski’s Rule of Five (Ro5), and Rule of Three (Ro3), followed by molecular docking. Results First, a total of 10 classical TCM formulas containing 94 BACs and corresponding to 15 syndromes were selected from 193 formulas. A total of 1 520 syndrome-related genes and 552 BAC targets were predicted. Additionally, 528 up-regulated and 697 down-regulated DEGs targeted by syndromes were identified. Enrichment analysis revealed that these DEGs were primarily involved in biological processes such as positive regulation of gene expression, neuronal anti-apoptosis, and synaptic function, and were significantly enriched in pathways such as phosphatidylinositol 3-kinase (PI3K)-protein kinase B signaling pathway (Akt) signaling, focal adhesion, and AD pathways. The BACs-DEGs-AD network indicated that up- and down-regulated DEGs could target 90 and 74 BACs, respectively, associated with nine syndromes. PPI network analysis identified five core AD genes with high degrees: beta-2 adrenergic receptor (ADRB2), substance-P receptor (TACR1), prostaglandin G/H synthase 2 (PTGS2), serine protease HTRA1A, and metabotropic glutamate receptor 1 (GRM1). Drug-likeness evaluation screened 22 candidate BACs, 11 of which were pharmacologically validated to have anti-AD activity. Molecular docking results showed that unii-x87dcb9gst exhibited superior comprehensive binding energy with the five core AD genes compared to marketed drugs such as donepezil, galantamine, and rivastigmine. Finally, molecular dynamics simulations further confirmed the stable binding of unii-x87dcb9gst to the acetylcholinesterase (AChE) complex. Conclusion This study identified AD biomarkers through multimodal algorithms and revealed AD-related biological processes and signaling pathways through enrichment analysis, providing molecular insights into the interaction mechanisms between TCM syndromes and AD genes. Additionally, unii-x87dcb9gst, screened as a candidate BAC from classical TCM formulas, may serve as a potential therapeutic agent for AD. This research not only offers a multidimensional understanding of AD pathogenesis but also establishes an innovative biomarker screening system and research paradigm for anti-AD drug development.
  • doi: 10.7501/j.issn.0253-2670.2025.09.019
    Objective To investigate the current research progress and future trends in the quality evaluation of Chinese medicinal materials through a bibliometric analysis of both Chinese and English literature. Methods China National Knowledge Infrastructure (CNKI) and Wanfang Database were used as the source of Chinese literature data, and Web of Science (WOS) was used as the source of English literature data. VOSviewer, CiteSpace, Scimago Graphica and other software were used to analyze and visualized the annual publication volume, journals, authors, institutions, keywords, etc. Results A total of 799 publications were retrieved, including 666 documents in Chinese and 133 documents in English. The research on the quality evaluation of Chinese medicinal materials is now in a stable development stage, with the number of publications increasing year by year. There is a clear modular distribution of collaborative relationships among authors, suggesting that we should strengthen collaboration across institutions and regions, as well as enhance the continuity of research themes. The research organization is represented by the Institute of Traditional Chinese Medicine of China Academy, which was the largest institutional cooperation center in this field. Of all the studies, National Natural Science Foundation of China (NSFC) was the largest source of funding. The innovation of Chinese literature based on emerging concepts, emerging models, evaluation systems and methods, which were the future research focus and development trend; The English literature mainly focuses on the identification and analysis of chemical components, involving more detailed technical operations and evaluation criteria. Conclusion The latest progress in this field mainly focuses on the proposal and application of new technologies and new evaluation models. However, challenges remain, including insufficient large-scale cooperation between teams and regions and a need to strengthen the sustainability of research. Notably, Japan may emerge as a strong competitor for the expansion of Chinese medicinal materials into the international market in China. How to improve the application stability of innovative technologies and build a safe, reliable, convenient and complete quality evaluation system are the focus and difficulties of future research.
  • doi: 10.7501/j.issn.0253-2670.2025.09.020
    Objective To evaluate the methodological and reporting quality of randomized controlled trials (RCTs) of traditional Chinese medicine (TCM) for the treatment of adenoid hypertrophy (AH) in children and analyze the current status of clinical trial design, in order to provide a reference for future RCTs of AH in children. Methods CNKI, Wanfang, VIP, SinoMed, PubMed, Cochrane Library, Embase, Web of Science, ClinicalTrials.gov, Chinese Clinical Trial Registry, and International Traditional Medicine Clinical Trial Registry were systematically searched for RCTs on TCM in the treatment of AH in children, with the time interval from database inception to May 15, 2024, RCTs were included according to the inclusion and exclusion criteria. The ROB 2.0 tool and the CONSORT-Outcomes 2022 extension were used to evaluate the methodological and reporting quality of the literature, respectively. The basic characteristics of clinical trial designs were summarized, with a focus on the analysis of outcome measures Results A total of 182 RCTs were included, including 178 articles and four registration information; the sample size was 14798 cases, concentrated in 60—100 cases (84.07%); the intervention measures were mainly Chinese herbal medicine (86.29%), and the control measures were mainly chemical drugs (74.73%); the treatment course was concentrated in 4—12 weeks (86.26%). The results of ROB 2.0 showed that the overall risk of bias of the literature was “some concerns” in 166 articles (93.3%) and “high risk of bias” in 12 articles (6.74%). The results of CONSORT-Outcomes 2022 Extension showed that the reporting rate of 41 items (75.93%) was less than 50%. A total of 90 outcome indicators were reported, with a frequency of 996 times, which were divided into eight indicator domains: nine TCM disease and syndrome indicators with a frequency of 264 times (26.51%), 50 physical and chemical examination indicators with a frequency of 256 times (25.70%), 13 symptom/sign indicators with a frequency of 244 times (24.50%), 8 safety event indicators with a frequency of 101 times (10.14%), six quality of life indicators with a frequency of 97 times (9.74%), two long-term prognosis indicators with a frequency of 32 times (3.21%), two other indicators with a frequency of 2 times (0.20%), and 0 economic evaluation indicators. Conclusion The overall quality of RCTs for TCM treatment of AH in children is poor, and there are many problems in the design of clinical trials. Future studies should prioritize rigorously designed trials that reflect TCM's clinical advantages to promote the transformation of clinical research into clinical application.
  • doi: 10.7501/j.issn.0253-2670.2025.09.021
    Objective To clone secologanin synthase (SLS) gene from Gentiana crassicaulis (GcSLS) and carry out physical and chemical properties, system evolutionary relationships, organization expression characteristic analysis. Methods Based on the annotation results of transcriptome data, we cloned the GcSLS from G. crassicaulis, analyzed its amino acid coding sequences and predicted the protein domains, physical and chemical properties and structure features. MEGA 11 software was used for evolutionary analysis. Quantitative PCR was employed to detect the expression levels of GcSLS in different tissues. Results We successfully cloned the GcSLS, and the ORF of GcSLS was 1 566 bp in length, encoding a 521 aa protein with a molecular weight of 59 590. It was a hydrophilic protein with a transmembrane domain, P450 conserved domains and no signal peptides. The results of quantitative PCR showed that the expression of GcSLS in roots and flowers was significantly higher than that in leaves and stems, and the expression of GcSLS was significantly induced by methyl jasmonate (MeJA). Conclusion The basic information, sequence characteristics and expression pattern of GcSLS may provide scientific data for further investigation of the function of GcSLS in the synthesis pathway of terpenoids.
  • doi: 10.7501/j.issn.0253-2670.2025.09.022
    Objective The gene AlCYP735A (GenBank: PP839072.1), coding for cytokinin hydroxylase in Atractylodes lancea was cloned for bioinformatic analysis, tissue-specific expression analysis, and recombinant expression using a prokaryotic expression vector. Method The full length of AlCYP735A was cloned from the cDNA of A. lancea, and its physicochemical properties were analyzed using bioinformatics tools. The tissue-specific expression of this gene was examined using qRT-PCR, and it was ligated into the pET28a-mbp expression vector and transformed into E. coli BL21 for expression of the recombinant protein. The subcellular localization prediction was carried out in tobacco leaves. Result The open reading frame of AlCYP735A is 1 566 bp, encoding 521 amino acids. It has a conserved P450 domain, with a relative molecular weight of 59 328.6 and an isoelectric point of 9.13. It contains a signal peptide and is classified as a secretory protein. The qRT-PCR results indicated that its expression is highest in the rhizome, significantly different from other tissues and organs. The recombinant protein mbp-AlCYP735A was solubly expressed, with a size consistent with the expected 106 700. Tobacco subcellular localization shows its localization in chloroplasts. Conclusion The successful cloning of the AlCYP735A gene, completion of bioinformatic analysis, determination of tissue-specific expression, soand subcellular localization in tobaccoluble and expression of the recombinant protein in the prokaryotic system provide the groundwork for subsequent functional validation of this gene.
  • doi: 10.7501/j.issn.0253-2670.2025.09.023
    Objective To study the content difference of isoquinoline alkaloids in different tissue parts of Phellodendron chinense var. glabriusculum and the genes related to biosynthesis Methods High performance liquid chromatography (HPLC) was used to determine the contents of root bark, stem bark and leaves of Amur barberberry, and transcriptome sequencing was used to screen key enzyme genes to explore the synthesis mechanism of isoquinoline alkaloids in P. chinense var. glabriusculum. Result The contents of isoquinoline alkaloids in root bark, stem bark and leaves were significantly different. 85 908 Unigenes were obtained by transcriptome sequencing, of which 49 114 (57.17%) were successfully annotated. 38 differentially expressed genes that catalyzed the production of isoquinoline alkaloids were successfully identified, and correlation analysis was conducted with isoquinoline components such as berberine. Eight genes were highly positively correlated with berberine content, including CNMT, NCS, TDC, BBE, TYNA and other genes, which may have important effects on the synthesis and accumulation of berberine genes. The expression pattern of differentially expressed genes was consistent with that of transcriptome data by qRT-PCR. Conclusion The significantly different expression patterns of isoquinoline alkaloid synthesis pathway related genes in different tissue parts of P. chinense var. glabriusculum were revealed, providing clues for further research on the molecular mechanism of isoquinoline alkaloid biosynthesis regulation.
  • doi: 10.7501/j.issn.0253-2670.2025.09.024
    Objective To undertake a comprehensive quality assessment of wild Baixianpi (Dictamni Cortex) samples from diverse origins through multi-index component quantification in conjunction with chemometrics and establish an origin identification model. Method The contents of five active components, namely limonin, wogonin, dictamnine, obacunone and fraxinellon, in wild Dictamni Cortex were concurrently determined by high performance liquid chromatography. The quality of wild Dictamni Cortex from different origins was evaluated by integrating correlation analysis, difference analysis, and principal component analysis. The origin identification model of wild Dictamni Cortex was constructed by applying systematic clustering, orthogonal partial least squares-discriminant analysis, and Fisher's linear discriminant. Results There were disparities in the determination outcomes of chemical components in wild Dictamni Cortex from different origins, which could be discriminated based on the contents of the five components. Among them, the samples from Inner Mongolia exhibited superior quality, followed by those from Liaoning, while the samples from Jilin presented slightly inferior quality. The origin could be initially identified through systematic clustering, yet some samples from Liaoning could still not be precisely identified. Orthogonal partial least squares-discriminant analysis could accurately categorize the origin of the samples, and the results of the Fisher's linear discriminant model could precisely discriminate the samples of wild Dictamni Cortex from unknown origins, with an accuracy rate of 100%. Conclusion The evaluation approach established by multi-index component quantification combined with chemometrics clarified the origins with better quality of wild Dictamni Cortex, evaluated the quality of wild Dictamni Cortex from different origins, and the established origin identification model of wild Dictamni Cortex was precise and reliable, providing a foundation for the quality control and rapid origin identification of wild Dictamni Cortex.
  • doi: 10.7501/j.issn.0253-2670.2025.09.025
    Objective To screen candidate endophytic fungi for the biocontrol of Scrophularia ningpoensis leaf spot disease and reveal their mechanism. Methods Based on the endophytic fungal strains isolated from S. ningpoensis, the antagonistic strains, were screened by plate confrontation trial with Phoma herbarum (PH) while using Trichoderma harzianum (TH) as an indicator. Control effect of endophytic fungi on the leaf spot of S. ningpoensis was investigated by in vivo leaf inoculation test, and the physiological indexes including plant protective enzyme activity, reactive oxygen species (ROS) level and salicylic acid (SA) content were determined. Further, the biocontrol strains were identified by ITS molecular sequence amplification. Results Among the 72 endophytic fungi tested, a total of 28 strains had significant inhibitory effects on PH, while endophytic fungus D90 had the highest inhibitory rate 0.833% ±0.030%. The results of in vivo inoculation of leaves showed that a total of four endophytic fungi had significant control effects on the leaf spot disease of S. ningpoensis, including D1, D3, D18 and D90, with the proportion of lesion area was (20.53 ±0.32)%, (2.07 ±0.05)%, (5.15 ±0.12)% and (1.92 ±0.08)%, respectively. D90 had the best control effect, with a control effect of 54.70%. D90 was identified as Colletotrichum fructicola. CAT activity of S. ningpoensis was significantly improved after inoculation of D90; On the 4th and 6th day of inoculation, compared with the leaf spot model group, D90 significantly increased the superoxide anion radical and lignin content of S. ningpoensis, but decreased the content of SA and NO in S. ningpoensis. Conclusion Endophytic fungus D90 has good biocontrol potential for S. ningpoensis leaf spot disease, this may be attributed to the improvement of CAT activity, ROS burst, and lignin content accumulation.
  • doi: 10.7501/j.issn.0253-2670.2025.09.026
    The quality uniformity and stability of traditional Chinese medicine (TCM), which affected by numerous factors including the diverse sources of Chinese medicinal materials (CMMs), stability in pharmaceutical equipment and processes, and the imperfections of quality standards, are the foundation to ensure the safety and efficacy of their clinical applications. As the starting raw materials, CMMs are the forefront of production chain, its quality evaluation and control play a key role in improving the quality of TCM. By summarizing the evaluation and control methods and genetic causes of quality fluctuations of CMMs and decoction pieces, the feasibility of genetic polymorphism methods such as DNA barcode inner-variants based on medicinal plant molecular genetics and herbgenomics to evaluate and control the quality uniformity of CMMs and decoction pieces. The strategies are proposed to enhance the accuracy of germplasm origin identification and control the chemical quality fluctuations within and between batches, focusing on quality uniformity control on TCM germplasm, cultivation, processing, material input, and production inspection, with view to promoting the uniformity and stability of CMMs and decoction pieces and driving the sustainable development of TCM health industry.
  • doi: 10.7501/j.issn.0253-2670.2025.09.027
    Acute lung injury (ALI), as a respiratory disease, can develop into acute respiratory distress syndrome in severe cases. Currently, the treatment of ALI in modern medicine is mainly based on mechanically assisted ventilation, anti-inflammation and hormonal therapy, but the effect of drug therapy is limited and mainly focuses on improving the pathological state of the lungs and relieving the symptoms of the disease, which has certain limitations. Therefore, finding a safe and effective method to prevent ALI is an important medical problem that needs to be solved urgently in clinical practice. The two-way communication hub between the intestine and the lungs can influence the immune status of the intestine and the lungs, and the interaction of intestinal flora through the “intestinal-lung axis” pathway plays an important role in the pathogenesis of ALI. Traditional Chinese medicine (TCM) also believes that the lungs and the large intestine are mutually exclusive, and that they are closely linked in terms of qi elevation, fluid metabolism, yin and yang, and meridians and so on. Therefore, TCM can regulate the intestinal-lung axis to promote the balance of intestinal microbiota and metabolites, inhibit oxidative stress and inflammation in lung tissues, and treat ALI by exerting the unique advantages of holistic regulation and multi-target interaction. Based on this, this article summarizes the mechanism of action and drug intervention of “gut-lung axis” in the treatment of ALI, and explores the association between intestinal flora imbalance and respiratory diseases, with a view to providing new insights for the prognosis of clinical ALI patients and exploring the prevention and treatment of ALI by the intervention of intestinal flora via the “gut-lung axis”.
  • doi: 10.7501/j.issn.0253-2670.2025.09.028
    Roucongrong (Cistanches Herba), a traditional Chinese medicinal material with extensive clinical applications, is known as the “Ginseng of the Desert”. In 2023, it has passed the evaluation of food safety and has been officially included in the directory of substances that are the same origin as food and medicine by the National Health Commission of China. It has found that plants of genus Cistanche are rich in a variety of primary metabolites, such as polysaccharides, organic acids, proteins, dietary fiber, mineral elements, amino acids, and vitamins, as well as secondary metabolites like phenylethanoid glycosides, iridoid glycosides, and lignans, etc. These compounds exhibit a range of pharmacological activities, including neuroprotection, moistening the intestines and relieving constipation, immune regulation, kidney and liver protection, anti-osteoporosis, anti-tumor, anti-inflammatory, and antioxidant effects. The primary metabolites, secondary metabolites, pharmacological activities and dual-use of Cistanchis plants were systematically reviewed in order to provide references for the clinical application, the development of medicine and food homology, and the comprehensive utilization of biological resources of Cistanches Herba active ingredients.
  • doi: 10.7501/j.issn.0253-2670.2025.09.029
    The integration of traditional processing methods with modern biotechnology in the fermentation of traditional Chinese medicine (TCM) plays a crucial role in ensuring the safety, efficacy, and stability of fermented TCM products. Quality evaluation is essential in this process, as it not only monitors key aspects such as microbial activity, metabolic product changes, and the transformation of active ingredients during fermentation but also provides a scientific basis for process optimization, strain selection, and the establishment of product quality standards. In recent years, significant progress has been made in the quality evaluation of fermented TCM. This review summarizes commonly used fermentation strains, the transformation of active ingredients, and quality evaluation methods, offering insights for process control and quality improvement of fermented TCM products.
  • doi: 10.7501/j.issn.0253-2670.2025.09.030
    Sangbaipi (Mori Cortex), derived from the dried root bark of Morus alba (Moraceae family), contains diverse chemical constituents including Diels-Alder adducts, flavonoids, stilbenes, coumarins, alkaloids, terpenes, and phenolic acids. It exhibits comprehensive pharmacological properties encompassing antihypertensive, hypoglycemic, hypolipidemic, antitussive, anti-asthmatic, expectorant, diuretic, anti-inflammatory, analgesic, antiviral, antitumor, antioxidant, hepatoprotective, and skin-whitening effects. This review synthesizes recent advances in the phytochemistry and pharmacodynamics of Mori Cortex to conduct predictive analysis of its quality markers (Q-Markers) through multidimensional evaluation criteria: geographical origin, processing techniques, measurability of chemical constituents, pharmacodynamic and property theories, network pharmacology, and blood-absorbed components. Tentatively proposed Q-Markers candidates include sweet mulberroside A, mulberroside C, sanggenon D, sanggenon C, moracin, kuwanon G, moracin M, and moracin D. These findings provide a scientific foundation for optimizing the quality evaluation system of Mori Cortex, bridging phytochemical characterization with therapeutic efficacy validation in traditional medicine research.
  • doi: 10.7501/j.issn.0253-2670.2025.09.031
    Under the combined effects of complex factors such as air pollution, occupational exposure, smoking, and passive smoking, the incidence of pulmonary diseases has been increasing annually. Conditions such as lung cancer, pulmonary fibrosis, and bronchial asthma have become major global public health challenges. Given the higher prevalence of these diseases among the elderly and their tendency to progress into chronic conditions, there is an urgent need for effective treatments with minimal adverse effects. Conventional chemical drugs, such as cephalosporin antibiotics, often lead to drug resistance and demonstrate limited therapeutic efficacy. Traditional Chinese medicine (TCM) has garnered increasing attention due to its multi-target, multi-pathway mechanisms and relatively high safety profile. Xihonghua (Croci Stigma) is known in TCM for its properties of cooling blood, detoxifying, promoting blood circulation, resolving stasis, and alleviating depression to calm the mind. Modern research has demonstrated that Croci Stigma exhibits various pharmacological activities, including antitumor, antiviral, anti-inflammatory, and antioxidative stress effects, with multiple mechanisms of action in prevention and treatment of pulmonary diseases. This review summarizes pharmacological effects of Croci Stigma and its bioactive constituents, as well as their mechanisms in managing pulmonary diseases, aiming to provide insights for future research and clinical applications.
  • doi: 10.7501/j.issn.0253-2670.2025.09.032
    Fulin (Ganoderma) has been used in China for more than 2 000 years as a precious traditional Chinese medicine that can be used both as food and medicine. The chemical constituents of Ganoderma include polysaccharides, polysaccharide peptides, triterpenoids, sterols, nucleosides, organic acids, etc., among which the main active components are polysaccharides and triterpenoids. Research progress on pharmacological activity of Ganoderma was reviewed in terms of immunomodulation, hepatoprotection, renal protection, antioxidant, antitumour, anti-inflammatory, hypolipidemic, hypoglycemic effects, and the biosynthetic pathways of Ganoderma polysaccharides and triterpenoids were summarized, so as to provide a reference basis for the evaluation of efficacy of high-quality Ganoderma and biosynthesis, as well as a scientific basis for the application of Ganoderma in health food and clinical applications.
  • doi: 10.7501/j.issn.0253-2670.2025.09.033
    Banxia Xiexin Decoction (半夏泻心汤) is a traditional Chinese medicine prescription derived from Treatise on Febrile and Miscellaneous Diseases. It has good clinical effect on treating many diseases. By systematically reviewing the clinical applications of Banxia Xiexin Decoction in different diseases and exploring its mechanism of action, it is found that Banxia Xiexin Decoction exerts effects such as regulating inflammatory factors, improving gastrointestinal motility function, and regulating the intestinal flora. It has significant curative effects on digestive system diseases such as gastroesophageal reflux disease, gastritis, peptic ulcer, and inflammatory bowel disease. In addition, the prescription has also shown good therapeutic effect in the fields of circulatory system diseases, skin diseases, neoplastic diseases and gynecological diseases. Banxia Xiexin Decoction has high safety and few adverse reactions, and is suitable for individualized treatment. Future studies should further explore its clinical application, active ingredients, mechanism of action and molecular targets to improve the scientific and accurate clinical application.
  • doi: 10.7501/j.issn.0253-2670.2025.09.034
    As an intangible cultural heritage of the Chinese nation, traditional Chinese medicine (TCM) has been deeply integrated into the global healthcare governance system. This article focuses on the study of the main alkaloid component, evodiamine (Evo), in the traditional Chinese herb Tetradium ruticarpum (A. Juss.) T. G. Hartley. Evo, an indole alkaloid, possesses various pharmacological activities such as anti-tumor, anti-inflammatory, antiemetic, analgesic, and antihypertensive effects. It has shown significant anti-tumor activity in various cancers including liver cancer, ovarian cancer, colorectal cancer, lung cancer, and kidney cancer. Exploring the molecular mechanisms of Evo's anti-tumor pharmacological effects is one of the key focuses in the research field of Evo-based anti-tumor drugs. Through comprehensive analysis of multiple domestic and international studies, this article reviews the specific molecular mechanisms of Evo's anti-tumor effects, including promoting tumor cell apoptosis, autophagy, and ferroptosis, blocking the cell cycle, influencing glucose metabolism, and regulating the tumor immune microenvironment. It also discusses the synergistic anti-tumor efficacy of Evo and the limitations of its clinical application, providing a reference for the development of Evo-based anti-tumor drugs.